Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
ABML
|
Douglas Charles Maclellan
Director |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 0.2% |
$24,000
$1.2 p/Share
|
Jan 08
2021 |
AKRO
|
Jonathan Young
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 5.28% |
$281,200
$28.12 p/Share
|
Jan 08
2021 |
LQDA
|
Eshelman Ventures, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 71,902 Reduced 1.14% |
$221,458
$3.08 p/Share
|
Jan 08
2021 |
JNCE
|
Elizabeth Trehu
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 2,846 Reduced 3.84% |
$19,922
$7.0 p/Share
|
Jan 08
2021 |
JNCE
|
Richard /Ca/ Murray
Director |
SELL
Open market or private sale
|
Direct | 11,816 Reduced 7.76% |
$82,712
$7.0 p/Share
|
Jan 08
2021 |
JNCE
|
Kimberlee C Drapkin
President, CFO and Treasurer |
SELL
Open market or private sale
|
Direct | 3,130 Reduced 5.3% |
$21,910
$7.0 p/Share
|
Jan 08
2021 |
JNCE
|
Hugh M Cole
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 3,340 Reduced 5.71% |
$23,380
$7.0 p/Share
|
Jan 08
2021 |
XGN
|
Hunt Holdings Limited Partnership
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 15,186 Reduced 1.04% |
$244,039
$16.07 p/Share
|
Jan 08
2021 |
LOV
|
Canaan Viii LP
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 0.27% |
$54,600
$5.46 p/Share
|
Jan 08
2021 |
KIRK
|
Jeffrey T. Martin
Sr. VP of Omni-Channel Retail |
SELL
Open market or private sale
|
Direct | 18,617 Reduced 15.81% |
$345,904
$18.58 p/Share
|
Jan 08
2021 |
MRNA
|
Stephane Bancel
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 11,046 Reduced 0.81% |
$1,267,197
$114.72 p/Share
|
Jan 08
2021 |
MA
|
Edward Grunde Mc Laughlin
President & CTO, MA Tech |
SELL
Open market or private sale
|
Direct | 13,248 Reduced 34.46% |
$4,647,133
$350.78 p/Share
|
Jan 08
2021 |
GTE
|
Gmt Capital Corp
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 291,724 Reduced 0.47% |
$128,359
$0.44 p/Share
|
Jan 08
2021 |
META
|
Mark Zuckerberg
COB and CEO |
SELL
Open market or private sale
|
Indirect | 44,750 Reduced 43.48% |
$11,918,715
$266.34 p/Share
|
Jan 08
2021 |
FISV
|
Guy Chiarello
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 7.4% |
$2,304,400
$115.22 p/Share
|
Jan 08
2021 |
AZO
|
Richard Craig Smith
Sr. Vice President |
SELL
Open market or private sale
|
Direct | 700 Reduced 18.84% |
$875,000
$1250.0 p/Share
|
Jan 08
2021 |
AZO
|
Mitchell C. Major
Sr. Vice President |
SELL
Open market or private sale
|
Direct | 2,130 Reduced 78.25% |
$2,653,703
$1245.87 p/Share
|
Jan 08
2021 |
HAL
|
Eric Carre
EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 2,350 Reduced 1.34% |
$48,598
$20.68 p/Share
|
Jan 08
2021 |
KMX
|
Eric M Margolin
EVP, Legal |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 38.03% |
$1,537,650
$102.51 p/Share
|
Jan 08
2021 |
BAH
|
Elizabeth M Thompson
EVP & Chief People Officer |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 35.9% |
$1,380,000
$92.0 p/Share
|
Jan 08
2021 |
RPM
|
Edward W. Moore
SVP, GC & CCO |
SELL
Open market or private sale
|
Direct | 8,811 Reduced 16.11% |
$763,737
$86.68 p/Share
|
Jan 08
2021 |
PLUG
|
Gerard L Conway Jr
Gen. Coun, Corp Sec., Exec. VP |
SELL
Open market or private sale
|
Direct | 33,333 Reduced 15.23% |
$1,735,649
$52.07 p/Share
|
Jan 08
2021 |
PLUG
|
George C Mcnamee
Director |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 1.11% |
$520,700
$52.07 p/Share
|
Jan 08
2021 |
MEDP
|
Medpace Investors, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 26,666 Reduced 0.41% |
$3,752,173
$140.71 p/Share
|
Jan 08
2021 |
MEDP
|
August J. Troendle
CEO |
SELL
Open market or private sale
|
Indirect | 26,666 Reduced 0.41% |
$3,752,173
$140.71 p/Share
|
Jan 08
2021 |
HQY
|
Frank Corvino |
SELL
Open market or private sale
|
Direct | 7,403 Reduced 63.95% |
$560,999
$75.78 p/Share
|
Jan 08
2021 |
WTS
|
Robert J Pagano Jr
President and CEO |
SELL
Open market or private sale
|
Direct | 18,758 Reduced 12.21% |
$2,365,759
$126.12 p/Share
|
Jan 08
2021 |
CVNA
|
Ernest C. Garcia Ii |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 100.0% |
$13,661,501
$273.23 p/Share
|
Jan 08
2021 |
HHC
|
Douglas Johnstone
Regional President, Hawaii |
SELL
Open market or private sale
|
Direct | 625 Reduced 17.96% |
$49,931
$79.89 p/Share
|
Jan 08
2021 |
LTHM
|
Paul W Graves
President and CEO |
SELL
Open market or private sale
|
Direct | 4,991 Reduced 2.02% |
$110,251
$22.09 p/Share
|
Jan 08
2021 |
SPT
|
Justyn Russell Howard
Executive Chair |
SELL
Open market or private sale
|
Indirect | 20,000 Reduced 75.27% |
$1,022,800
$51.14 p/Share
|
Jan 08
2021 |
TRIP
|
Ernst 02494 Teunissen
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 32,722 Reduced 100.0% |
$1,112,548
$34.0 p/Share
|
Jan 08
2021 |
MYGN
|
Paul Parkinson
EVP Strategy and Innovation |
SELL
Open market or private sale
|
Direct | 11,824 Reduced 13.35% |
$295,600
$25.0 p/Share
|
Jan 08
2021 |
ADPT
|
Julie Rubinstein
President and COO |
BUY
Open market or private sale
|
Direct | 6,186 Added 55.58% |
$373,882
$60.44 p/Share
|
Jan 08
2021 |
ADPT
|
Julie Rubinstein
President and COO |
SELL
Open market or private sale
|
Direct | 8,814 Reduced 100.0% |
$528,487
$59.96 p/Share
|
Jan 08
2021 |
INGN
|
Brenton Taylor
EVP, Engineering |
SELL
Open market or private sale
|
Direct | 11,017 Reduced 16.3% |
$519,892
$47.19 p/Share
|
Jan 08
2021 |
REAL
|
Julie Wainwright
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 165,000 Reduced 4.88% |
$4,055,700
$24.58 p/Share
|
Jan 08
2021 |
FSBW
|
Mark Tueffers |
SELL
Open market or private sale
|
Indirect | 423 Reduced 5.95% |
$25,380
$60.0 p/Share
|
Jan 08
2021 |
EIGR
|
Eldon C. Mayer Iii
Ex VP & Chief Commerc. Officer |
SELL
Open market or private sale
|
Direct | 1,690 Reduced 4.51% |
$19,739
$11.68 p/Share
|
Jan 08
2021 |
HOFT
|
Paul B Toms Jr
Director |
SELL
Open market or private sale
|
Direct | 14,993 Reduced 19.6% |
$467,332
$31.17 p/Share
|
Jan 08
2021 |
BDTX
|
Thomas Leggett
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 100.0% |
$101,820
$33.94 p/Share
|
Jan 08
2021 |
MLSS
|
Joseph D'Agostino
CFO & COO |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 1.95% |
$46,000
$2.3 p/Share
|
Jan 08
2021 |
ACBI
|
Robert R Bugbee Ii
CHIEF CREDIT OFFICER |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 2.63% |
$16,850
$16.85 p/Share
|
Jan 08
2021 |
ESNT
|
Mary Lourdes Gibbons
SVP and Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 1,400 Reduced 0.66% |
$67,200
$48.0 p/Share
|
Jan 08
2021 |
SQ
|
Amrita Ahuja
CFO & COO |
SELL
Open market or private sale
|
Direct | 1,138 Reduced 0.72% |
$278,070
$244.35 p/Share
|
Jan 08
2021 |
CVS
|
Alan Lotvin
EVP&President-PharmacyServices |
SELL
Open market or private sale
|
Direct | 25,836 Reduced 75.54% |
$1,937,700
$75.0 p/Share
|
Jan 08
2021 |
CVS
|
Troyen A Brennan
EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 58,896 Reduced 56.14% |
$4,417,200
$75.0 p/Share
|
Jan 08
2021 |
AMT
|
Olivier Puech
EVP & President, International |
SELL
Open market or private sale
|
Direct | 320 Reduced 1.83% |
$70,400
$220.0 p/Share
|
Jan 08
2021 |
GNK
|
Strategic Value Partners, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 795,441 Reduced 10.96% |
$6,824,884
$8.58 p/Share
|
Jan 08
2021 |
AN
|
Edward S Lampert |
SELL
Open market or private sale
|
Direct | 3,989 Reduced 0.04% |
$303,563
$76.1 p/Share
|
Jan 08
2021 |